Responses
Clinical and epidemiological research
Extended report
Anticarbamylated protein antibodies are associated with long-term disability and increased disease activity in patients with early inflammatory arthritis: results from the Norfolk Arthritis Register
Compose a Response to This Article
Other responses
No responses have been published for this article.